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1146-32 Pat ients  on Lipid-Lowering Therapy at the Time of a 
Myocardial Infarction Have Smaller Infarcts: Further 
Evidence to Suggest a Salutary  Ef fect  in Acute 
Coronary  Syndromes 
Herbert D. Aronow. Thomas McRae, Martin J. Quinn, Eric J, Topoi, Michael Lincoff, 
Penny L. Houghtaling, Michael S. Lauer, Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: By virtue of their effects on thrombosis and the coronary micro- and mac- 
rovasculatura, it is plausible that lipid-lowering agents (LLA) might reduce infarct size. 
Methods: We compared infarct size among patients in the GUSTO lib and PURSUIT tri- 
als who were (n=fO48) or were not (n=9672) on a LLA prior to an enrolling myocardial 
infarction (MI). A propensity analysis was used to match patients on the probability of 
LLA treatment prior to the index admission. 
Results: In the overall (n=10720) and propensity-matched (n=6568) cohorts, the median 
CK-MB level was significantly lower among patients who were on a LLA prior to admis- 
sion (4,0 vs. 5.0 X ULN, p<0.0001 and 4.4 vs. 4.0, p=0.01, respectively). In the propen- 
sify-matched cohort, fewer patients on a LLA before their MI had a CK-MB >= 3X ULN 
(58 vs. 63%, Risk Ratio [RR] = 0.92, 95% CI 0.87-0.97, p=0.002). After adjusting for 
other potential confounders and the propensity score, LLA pre-treatment was associated 
with smaller infarct size (RR for CK-MB >= 3X ULN = 0.94, 95% CI 0.88-0.99), p = 0.04). 
Conclusion: Patients on a LLA prior to sustaining an MI had significantly smaller infarcts. 
These findings provide further evidence to suggest that lipid-lowering therapy may exert 
salutary effects in the setting of an acute coronary syndrome. 
1146-33 Nonse lect ive  Nonaapi r in  Nonatero ida l  Ant l in f lammatory  
Medications Are Associated With Reduced Risk of 
Myocardial Infarction 
Steoherl E. Kimmel. Jesse A. Berlin, Muradach Reilly, Jane Jaskowiak, Lori Kishel, Brian 
L. Strom, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 
Center for Clinical Epidemiology and Biostatistics, Philadelphia, Pennsylvania. 
Background: Non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit 
both cyclooxygenase-1 (COX-l) and COX-2 (i.e., nonselective NSAIDs) may reduce the 
risk of myocardial infarction (MI) through reversible inhibition of platelet function. Knowl- 
edge of the affects of nonselective NSAIDs on MI could aid in interpreting recent trials 
comparing nonselective NSAIDs with COX-2 inhibitors. 
Methods: A case-control study of first MI, ages 40 through 75, was conducted among 36 
hospitals in a 5-county area during a 26-month period in 1999-2001. Cases were patients 
hospitalized with a first MI, and controls were randomly selected from the same geo- 
graphic area. Detailed information regarding NSAID use in the week before the MI for 
cases and before the interview for controls was collected via telephone interviews using 
state-of-the-art methods, including NSAID picture prompts. Nonselective NSAID use was 
compared with no use in the prior week. Multivariable logistic regression was used to 
adjust for age, sex, body mass index, family history, cigarette smoking, insurance, exer- 
cise, and history of coronary disease, heart failure, hypertension, hypercholesterolemia, 
diabetes, or arthritis. COX-2 inhibitor use during this time period was low and therefore 
not included. 
Results: 909 cases (21% nonselective NSAID users in the prior week) and 3030 controls 
(34% nonselective NSAID users) were interviewed. There was a significant protective 
effect against MI for nonselective NSAID use in both the prior week [multivariable odds 
ratio (OR) 0.67, 95% confidence interval (CI): 0.54-0.82)] and the prior 24 hours (multi- 
variable OR 0.61, 95% CI: 0.46-0.80). However, there was a significant interaction 
between current aspirin (ASA) usa (within the index week) and NSAIDs: NSAIDs were 
protective among those not using ASA (OR 0.56; 95% CI: 0.44-0.72), but were not pro- 
tective among ASA users (OR 1.01; 95% Cl: 0.69-1.47; interaction P<0.01). 
Conclusion: Current use of nonselective NSAIDs is associated with a reduced odds of 
MI. Among ASA users, however, there is no effect of NSAID use on MI risk. 
114@34 High Fasting Insulin Levels in Patients With Coronary  
Artery Disease and No Known Diabetes is a Potent 
Predictor of Future Cardiac Events 
Michael Anoioi, Pierre Theroux, MONTREAL HEART INSTITUTE, MONTREAL, Quebec, 
Canada. 
Background: Hyperinsulinism is believed to be one mechanism contributing to coronary 
artery disease (CAD) in diabetic patients. However, the potential deleterious effect of 
hyperinsulinemis in non-diabetics has not yet been assessed. 
Methods: A sub-population of non-diabetic patients was extracted from a prospective 
case-control cohort study that examine biological and genetic markers associated with 
CAD and subsequent prognosis All patients included in this study had angiographically- 
documented CAD. Major adverse cardiac events (MACE) recorded during 1-year FU 
were death, myocardial infarction (MI), myocardial revascularisation (either PTCA or 
CABG) and hospitalization for acute coronary syndrome (ACS). 
Results: The study population included 303 non-diabetic patients (male 79%, age: 58 
_+10 years). Risk factors in these patients were smoking in 83%, systemic hypertension in 
39% and hypercholasterolemia in 77%, in addition prior MI, PTCA and CABG were 
present in 53%, 68% and 22% of patients, respectively. Biologic screening included, D- 
dimers, homocysteine, CRP, fibrinogen, Lp(a), folates and insulin plasma levels. During 
FU, 49 pts (16%) had at least 1 event (death 3, MI 5, ACS 18, myocardial revascularisa- 
tion 40). Among the studied characteristics, insulin levels were the most potent and sin- 
gle independent predictor of MACE. Kaplan-Meier probabilities of survival without events 
were 87% in the low tertile of insulin (<50 pmoles/L), 88% in the medium tertile (50 to 82 
pmole/L) and 76 % in the high tertile (>82 pmole/L) (low vs. high: RR=2.19, 95%CI 1.0- 
4.6, p<0.019 and medium vs. high: RR=2.4, 95%CI 1.1-5.1, p<0.016) Baseline levels of 
insulin correlated with fibrinogen (R=0.17, p<0.003) CRP (R=0.16, p<0.005) and body 
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mass index (R=0.4, p<0.0001). 
Conclusion: Hyberinsulinemia in non-diabetic patients with CAD is associated with ele- 
vated inflammatory markers and is a strong predictor of future cardiac events. 
1146-35 Acute Myocardial Infarction and Renal Failure: Impact  
of Treatment on Short end Long-Term Surv iva l  
R. Scott Wriaht. Joseph G. Murphy, Charles A. Herzog, Guy S. Reeder, Wayne L. Miller, 
Stephen L. Kopeck'y, Robed C. Albright, Brant A. Williams, Allan S. Jade, Mayo Clinic 
and Foundation, Rochester, Minnesota, University of Minnesota School of Medicine and 
Hennepin County Medical Center, Minneapolis, Minnesota. 
Background: Patients with severe renal failure have reduced survival following acute 
myocardial infarction (AMI). Few data are available about management of AMI in these 
populations including the impact of aggressive treatment on outcome following AMI. 
Methods: We stratified 3205 patients with AMI by creatinine clearance (CC): CC>75 cc/ 
min (n=965), CC 50-75 cc/min (n=919), CC 35-50 cc/min (n=694), CC<35 cc/min 
(n=694) and end stage renal disease (ESRD) on dialysis for at least one month prior to 
index AMI (n=46). We compared treatment strategies during the hospitalization for AMI 
and estimated the influence on treatment strategies with regard to in-hospital and tong- 
term survival by CC. 
Results: The use of aspirin, heparin and beta blockers were significantly higher in those 
with normal renal function compared to any degree of renal failure, all p<0.001. Acute 
reperfusion therapy was more frequently utilized in patients without renal failure (31.9%) 
compared to ESRD (6.5%), severe renal failure (13.0%), moderate renal failure 
(21.2%)and mild renal failure (25.2%), p<0.001, The influence of these therapies on sur- 
vival is depicted (Table). 
Conclusions: Patients with any degree of renal disease have increased mortality risks 
following AMI, and those with severe renal failure have similar survival to those with 
ESRD. The estimation CC at time of admission with AMI may help better identify patients 
with increased mortality risks. 
Predictors of Mortality 
In-Hospital Mortality 
Adjusted model results: RR CI p-value 
Killip Class (>1 vs I) 2.65 (1.99, 3.53) <0.001 
Age (>75 vs < 65) 1.64 (1.06, 2.52) 0.025 
Age (65-75 vs < 65) 1.45 (0.94, 2.24) 0.091 
Diabetes 1.44 (1.05, 1.98) 0.024 
Gender (female vs male) 0.73 (0.54, 0.97) 0.030 
ACEI use w/in 24h of admit 0.40 (0.27, 0.60) <0.001 
Aspirin use w/in 24h 0.40 (0.30, 0.54) <0.001 
Post-Discharge Mortality 
Adjusted model results: RR CI p-value 
Age (>75 vs <65) 2.86 (2.14, 3.83) <0.001 
Killip class (>1 vs I) 1.80 (1.51, 2.15) <0.001 
Age (65-75 vs <65) 1.78 (1.33, 2.37) <0.001 
Stroke 1 .71  (1.41,2.08) <0.001 
Diabetes 1.39 (1.15, 1.68) <0.001 
Prior MI 1.34 (1.12, 1.60) 0.002 
Aspirin use at d/c 0.65 (0.53, 0.80) <0.001 
~-blocker use at d/c 0.72 (0.61,0.86) <0.001 
Primary Repeffusion 0.73 (0.58, 0.92) 0.007 
1146-36 Bradycardia ,  Hypotension, and Chronotropic 
Incompetence Are Common With Acute Proximal 
Versus Distal RCA Occlusion 
James A. Goldstein, Daniel T. Lee, Terry Bowers, Cindy L. Grines, Mark Pica, William W. 
O'Neill, William Beaumont Hospital, Royal Oak, Michigan. 
Background: Bradycardia and hypotension commonly complicate inferior Mt and are 
thought o be mediated by Bezold-Jarisch reflexes arising from the ischemic LV inferior 
wall. Pts with RV infarction due to proximal RCA occlusion (occlx) are especially prone to 
brsdycardia and hypotension, although the reasons for this proclivity have not been 
delineated. We hypothesized that proximal vs distal ecclx of the RCA plays a role. Meth- 
ods: In 205 pts with tMI undergoing I ° PTCA, we defined the location of RCA occlx as 
proximal to the RV branches or distal to the RV branches but compromising the LV 
branches. We analyzed charts for the development of bradycardia (<50/rnn), hypoten- 
sion (syst BP<90 mm Hg) and bradycardia-hypotansion (syst BP<90 + HR<50). Results: 
We identified proximal RCA occlx in 163(76%) pts and distal occlx in 52(24%) others. 
Compared to those with distal occlx, pts with proximal occlx more frequently developed 
bradycsrdia (23 vs 10%, p=.05); and hypotension (45 vs 29%, p=.01). Interestingly, in pts 
with prox occlx developing hypotension, whereas frank bradycardia (<50/ran) occurred in 
32% of cases, the heart rate was <t 00 in 94% of such patients, such lack of compensa- 
tory sinus tachycardia indicative of chronotropic incompetence. Conclusions: These 
results indicate that acute proximal RCA occlx compromising flow to the RV branches as 
well as the LV inferior wall commonly results in hypotension with chronotropic incompe- 
tence, as well as frank bradycardia. These phenomenon are less common with distal 
occ~x inducing LV ischemia alone, suggesting that reflex mechanisms originating from 
the ischemic right heart may play a mechanistic role. 
